Cytokinetics reported $353.42M in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 332.22M 29.22M Sep/2026
Amgen USD 23.23B 2.27B Sep/2026
Arca Biopharma USD 31.78M 8.81M Sep/2026
Bayer EUR 29.4B 2.87B Sep/2026
Biogen USD 3.9B 18.7M Sep/2026
Brainstorm Cell Therapeutics USD 12.38M 621K Jun/2026
Bristol-Myers Squibb USD 18.75B 94M Sep/2026
Capricor Therapeutics USD 29.9M 3.07M Sep/2026
Cytokinetics USD 353.42M 171.99M Sep/2026
Eisai JPY 371.5B 22.14B Sep/2026
Eli Lilly USD 47B 745M Sep/2026
Exelixis USD 411.88M 49.95M Sep/2026
Geron USD 74.25M 3.92M Sep/2026
Halozyme Therapeutics USD 476.09M 131.65M Sep/2026
Ionis Pharmaceuticals USD 435.29M 119.65M Sep/2026
Ligand Pharmaceuticals USD 500.57M 453.83M Sep/2026
Merck USD 28.8B 1.07B Sep/2026
Novartis USD 32.52B 777M Sep/2026
Pfizer USD 31.73B 920M Sep/2026
Regeneron Pharmaceuticals USD 6.2B 671.5M Sep/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 29.77B 2.16B Sep/2026